Daxor Debuts FDA-Cleared BVA Technology for Kidney Fluid Management
1 report, 1 independent
Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Daxor is utilizing BVA™ technology to deliver precise volume measurement for fluid management in complex kidney care. The platform, which measures total blood, red blood cell, and plasma volume, is FDA-cleared and was showcased at ASN Kidney Week 2026.
From manilatimes.net
Why it matters
The technology addresses challenges in patients with renal disease, including cardiorenal syndrome and acute kidney injury, where traditional markers often fail to accurately reflect fluid status. This provides lab-accurate metrics for safer volume unloading in complex renal care.
From manilatimes.net